Sildenafil Citrate Tablet, Film Coated
Product Images NDC 71205-305

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 71205-305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-305-30 (Sildenafil Tablets Usp 20mg 90 Label)

Sildenafil 20 mg film-coated tablets packaging label from Proficient Rx LP. The label states a quantity of 30 tablets, each containing Sildenafil citrate USP equivalent to 20 mg sildenafil. Manufacturer is Rubicon Research Private Limited in India. Instructions include storage at 20°-25°C and a warning to keep out of reach of children. The label includes NDC 71205-305-30 and a QR code.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 06)

A line graph showing the estimated cumulative mortality rate (%) over time in years for three dosing groups labeled High Dose, Medium Dose, and Low Dose. The vertical axis represents the mortality rate from 0 to 25%, and the horizontal axis represents time from 0 to 5 years. Stepwise lines depict increasing mortality rates over time, with the high dose group having the highest rate, followed by medium and low doses. A table above the plot shows the number of subjects at risk at various time points for each dose group.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 07)

A forest plot chart depicting the effect of various interacting drugs on the pharmacokinetics of Sildenafil. It shows the fold change and 90% confidence intervals for AUC and Cmax, with a reference line at 1 representing Sildenafil alone. The chart includes recommendations on dose adjustment for each interacting drug listed.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 08)

A chart showing fold change and 90% confidence intervals comparing combined effects of Sildenafil with various interacting drugs. The y-axis lists interacting drugs such as Acenocoumarol, Aspirin, Atorvastatin, and others, while the x-axis shows change relative to the interacting drug alone. Data points represent variations in INR AUC, INR Cmax, BT, AUC, and Cmax metrics. Recommendations on dose adjustment are included, with most indicating no dose adjustment needed except for Ritonavir, where coadministration is not recommended.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 09)

A line chart showing change from baseline in meters over 12 weeks for a study with Sildenafil tablets. The x-axis represents weeks of study (Week 4, Week 8, Week 12) and the y-axis represents change from baseline (meters). Four groups are plotted: Placebo, Sildenafil 20 mg TID, Sildenafil 40 mg TID, and Sildenafil 80 mg TID, with markers and error bars indicating variability at each time point.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 10)

A forest plot chart illustrating placebo-corrected changes in 6-minute walk distance (meters) with Sildenafil 20 mg TID across various subgroups. Subgroups include baseline walk distance, etiology of pulmonary arterial hypertension, PH functional class, gender, age, mean pulmonary artery pressure, and pulmonary vascular resistance index. Each subgroup shows sample sizes and effect estimates with confidence intervals.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 11)

A Kaplan-Meier survival curve comparing the percentage of subjects without a clinically worsening event over time between placebo and Sildenafil groups. The x-axis represents days from randomization (0 to 112), and the y-axis shows the percentage without event (0 to 100%). Two lines depict outcomes for placebo and Sildenafil.*

FDA Label Image

Graph (Sildenafil Tablets Usp 20mg Figure 12)

A line graph showing the mean change from baseline in meters over a 12-week study period for three Sildenafil dosages (1 mg, 5 mg, and 20 mg taken TID). Data points at weeks 4, 8, and 12 include standard error bars illustrating treatment effects compared to baseline.*

FDA Label Image

Structure Formula (Sildenafil Tablets Usp 20mg Structure)

Chemical structure of Sildenafil, the active ingredient in Sildenafil Citrate tablets. The diagram displays its molecular bonds and functional groups clearly labeled.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.